SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Mar-24 5:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-24 | Payment of Exercise | 3,531 | $1.24 | $4,378.44 | (2%) 190.51K to 186.98K | |
05-Mar-24 5:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-24 | Option Exercise | 12,500 | -- | -- | 7% 178.01K to 190.51K | |
05-Mar-24 5:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Mar-24 | Payment of Exercise | 17,752 | $1.24 | $22,012.50 | (9%) 195.76K to 178.01K | |
05-Mar-24 5:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Mar-24 | Option Exercise | 60,925 | -- | -- | 45% 134.83K to 195.76K | |
05-Feb-24 7:31 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-24 | Payment of Exercise | 2,583 | $1.20 | $3,099.60 | (2%) 137.42K to 134.83K | |
05-Feb-24 7:31 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-24 | Option Exercise | 7,500 | -- | -- | 6% 129.92K to 137.42K | |
25-Oct-23 4:28 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 23-Oct-23 | Sale (Planned) | 6,000 | $5.08 | $30,460.20 | (4%) 135.92K to 129.92K | |
22-Aug-23 4:31 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 21-Aug-23 | Sale (Planned) | 6,000 | $7.32 | $43,894.80 | (4%) 141.92K to 135.92K | |
22-Jun-23 4:30 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 20-Jun-23 | Sale (Planned) | 6,000 | $10.28 | $61,662.60 | (4%) 147.92K to 141.92K | |
03-Mar-23 10:00 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Mar-23 | Option Sale | 16,037 | $12.63 | $202,615.00 | (10%) 163.95K to 147.92K | |
03-Mar-23 10:00 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-23 | Option Exercise | 12,500 | -- | -- | 8% 166.25K to 178.75K | |
03-Mar-23 10:00 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-23 | Option Sale | 14,800 | $12.37 | $183,024.00 | (8%) 178.75K to 163.95K | |
03-Mar-23 10:00 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Mar-23 | Option Exercise | 74,675 | -- | -- | 82% 91.58K to 166.25K | |
17-Feb-23 4:34 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Feb-23 | Market Sale (Planned) | 5,000 | $13.06 | $65,310.50 | (5%) 96.58K to 91.58K | 5% |
16-Dec-22 4:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Dec-22 | Private Sale (Planned) | 5,000 | $15.88 | $79,411.50 | (5%) 101.58K to 96.58K | |
19-Oct-22 4:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 17-Oct-22 | Private Sale (Planned) | 5,000 | $15.98 | $79,907.50 | (5%) 106.58K to 101.58K | |
20-Apr-22 5:06 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Apr-22 | Private Sale (Planned) | 30,000 | $16.28 | $488,298.00 | (22%) 136.58K to 106.58K | |
14-Mar-22 4:53 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 10-Mar-22 | Private Sale | 27,165 | $15.71 | $426,803.00 | (17%) 163.74K to 136.58K | |
03-Mar-22 6:11 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-22 | Option Exercise | 12,500 | -- | -- | 8% 151.24K to 163.74K | |
03-Mar-22 6:11 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Mar-22 | Option Exercise | 63,750 | -- | -- | 73% 87.49K to 151.24K | |
11-Feb-22 4:22 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 09-Feb-22 | Market Sale | 383 | $12.68 | $4,857.13 | (< 1%) 87.88K to 87.49K | 2% |
03-Feb-22 10:00 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-22 | Option Exercise | 1,050 | -- | -- | 1% 86.83K to 87.88K | |
02-Sep-21 5:39 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Sep-21 | Payment of Exercise | 1,041 | $17.22 | $17,926.00 | (1%) 87.87K to 86.83K | |
02-Sep-21 5:39 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Sep-21 | Option Exercise | 2,333 | -- | -- | 3% 85.53K to 87.87K | |
02-Jun-21 9:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Jun-21 | Market Option Sale | 21,790 | $21.64 | $471,437.00 | (20%) 107.33K to 85.53K | |
02-Jun-21 9:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jun-21 | Option Exercise | 50,000 | -- | -- | 87% 57.33K to 107.33K |